SynthesisFrontiers in microbiology2025
The characteristics of the gut microbiota in patients with Kawasaki disease: a systematic review.
Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- The gut microbiota and kawasaki disease: exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics.European journal of pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut-vascular axis has emerged as a critical focus of research, with accumulating evidence suggesting distinct alterations in intestinal microbiota among patients with Kawasaki disease (KD). However, no systematic review to date has comprehensively characterized gut microbial dysbiosis in this population. This systematic review aimed to investigate changes in the composition of gut microbiota in KD patients. A comprehensive search of MEDLINE, EMBASE, Web of Science, and the Cochrane Library databases was conducted, and the study quality was assessed using the Newcastle-Ottawa Scale. All reported taxa were re-annotated according to the SILVA 138 database. Seven studies were enrolled in our review. In acute-phase KD, reduced Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251148103.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.